Group 1 - The fourth meeting of the board of directors of Qingdao Inpace Health Technology Co., Ltd. was held on August 29, 2025, with all 9 directors present, ensuring compliance with relevant laws and regulations [1][2]. - The board unanimously approved several resolutions, including the review of the 2025 semi-annual report and the special report on the management and use of raised funds [1][2]. - The company plans to hold its first extraordinary general meeting of shareholders on September 16, 2025, combining on-site and online voting [2][3]. Group 2 - The resolutions passed included the approval of changes to the company's registered address and amendments to the articles of association, pending shareholder approval [2]. - The voting results for all resolutions were 9 votes in favor, with no votes against or abstentions [2][3]. - Detailed reports related to the resolutions were published on various financial news platforms and the company's official website [1][2][3].

Group 1 - The third meeting of the fourth Supervisory Board of Qingdao Inspurs Health Technology Co., Ltd. was held on August 29, 2025, with all three supervisors present, confirming compliance with relevant laws and regulations [1] - The Supervisory Board approved the procedures for the preparation and review of the 2025 semi-annual report, stating that the report accurately reflects the company's actual situation without any false records or misleading statements [2][3] - The management and use of raised funds were found to comply with the relevant regulations, and the special report on the management and use of raised funds was deemed to accurately reflect the actual situation [2][3]

Meeting Announcement - Qingdao Impulse Health Technology Co., Ltd. will hold its first extraordinary general meeting of shareholders in 2025 on September 16, 2025, as approved by the board on August 29, 2025 [1][2] - The meeting will be conducted in a hybrid format, combining on-site attendance and online voting through the Shenzhen Stock Exchange systems [2][5] Voting Procedures - Shareholders can choose either on-site voting or online voting, but not both. In case of duplicate votes, the first valid vote will be counted [2][6] - The voting will take place on September 16, 2025, with specific time slots for online voting through the Shenzhen Stock Exchange trading system and internet voting system [2][6] Meeting Agenda - The main agenda item for the meeting is to discuss the proposal for changing the registered address and amending the company's articles of association, which has already been approved by the board [2][3] - A special resolution requires approval from more than two-thirds of the voting rights held by shareholders present at the meeting [3] Registration and Attendance - Shareholders must register for the meeting by providing necessary identification and documentation, either in person or through a proxy [3][4] - The registration deadline for mail or fax submissions is September 15, 2025, by 17:00 [4][5] Additional Information - The meeting is expected to last half a day, and attendees will be responsible for their own travel and accommodation expenses [5] - Detailed instructions for participating in online voting are provided, including the need for identity verification [6]

Core Viewpoint - The report highlights the financial performance and operational strategies of Qingdao Impulse Health Technology Co., Ltd. for the first half of 2025, indicating a slight increase in revenue but a significant decline in net profit, reflecting challenges in the current economic environment and market dynamics [1][19]. Financial Performance - The company achieved a revenue of 574.49 million yuan, a 0.47% increase compared to the same period last year [7][19]. - The net profit attributable to shareholders was 31.67 million yuan, representing a 38.09% decrease year-on-year [19]. - Basic and diluted earnings per share were both 0.22 yuan, down 45% from the previous year [7]. Business Overview - The company specializes in the development, manufacturing, and sales of a wide range of fitness equipment, focusing on functional, intelligent, and safe products to meet diverse consumer needs [7][11]. - The product lines include commercial, home, and outdoor fitness equipment, catering to various customer segments [7][11]. - The company has established a nationwide sales network in China and successfully penetrated international markets, including Europe and Asia-Pacific, under its own brand IMPULSE [11][19]. Market Dynamics - The fitness equipment market is experiencing steady growth driven by increasing health awareness and rising living standards among consumers [19][20]. - The domestic retail sales of sports and entertainment products grew by 22.2%, indicating a strong demand for fitness-related products [19]. - The company faces competition from both international brands and domestic players, with a focus on high-end and mid-range markets [17][19]. Strategic Initiatives - The company is actively pursuing digital transformation and enhancing operational efficiency through smart manufacturing and supply chain optimization [19][20]. - It is expanding its overseas market presence through OEM/ODM partnerships and direct sales of its own brand products [20][21]. - The company participates in major international trade exhibitions to showcase its products and enhance brand visibility [21]. Industry Trends - The fitness industry is supported by favorable government policies aimed at promoting sports and fitness, which are expected to drive market growth [14][21]. - There is a growing trend towards smart and personalized fitness solutions, with increasing demand for home fitness equipment as consumers seek to create personal workout spaces [15][16]. - The market is witnessing a shift towards digital and intelligent fitness services, with new business models emerging in response to changing consumer preferences [15][19].

Core Viewpoint - Qingdao Impulse Health Technology Co., Ltd. reported a slight increase in revenue but a significant decline in net profit for the first half of 2025 compared to the same period last year [1]. Financial Performance - Operating revenue for the reporting period was approximately 574.49 million yuan, a 0.47% increase from 571.83 million yuan in the same period last year [1]. - Net profit attributable to shareholders was approximately 31.67 million yuan, representing a 38.09% decrease from 51.16 million yuan year-on-year [1]. - The net profit after deducting non-recurring gains and losses was approximately 28.73 million yuan, down 40.46% from 48.26 million yuan in the previous year [1]. - The net cash flow from operating activities was approximately 51.82 million yuan, an increase of 89.22% compared to 27.39 million yuan in the same period last year [1]. - Basic and diluted earnings per share were both 0.22 yuan, a decrease of 45.00% from 0.40 yuan [1]. Asset and Equity Position - Total assets at the end of the reporting period were approximately 2.86 billion yuan, a decrease of 3.01% from 2.95 billion yuan at the end of the previous year [2]. - Net assets attributable to shareholders were approximately 1.72 billion yuan, reflecting a 1.22% increase from 1.70 billion yuan at the end of the previous year [2]. Shareholder Information - The largest shareholder, Hainan Jiangheng Industrial Investment Co., Ltd., holds 27.51% of the shares, amounting to 40.66 million shares, with some shares pledged [2]. - Other significant shareholders include Anhui Jingxi Private Fund Management Co., Ltd. and Shenzhen Hanqing Technology Co., Ltd., holding 2.44% and 1.09% of shares, respectively [3]. Important Matters - There were no changes in the controlling shareholder or actual controller during the reporting period [4].

证券代码：002899 证券简称：英派斯 公告编号：2025-033 青岛英派斯健康科技股份有限公司 | 修订前 | | | 修订后 | | --- | --- | --- | --- | | 第五条 | 公司住所：青岛市即墨市华山 | 第五条 | 公司住所：山东省青岛市即墨 | | 二路 369 号 | | 区马山路 297 号 | | | 邮政编码：266200 | | 邮政编码：266200 | | 关于变更注册地址、修订《公司章程》并办理工商变更登记的 公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有 虚假记载、误导性陈述或重大遗漏。 一、基本情况概述 青岛英派斯健康科技股份有限公司（以下简称"公司"）于 2025 年 8 月 29 日召开第四届董事会 2025 年第四次会议，审议通过了《关于变更注册地址、修 订<公司章程>并办理工商变更登记的议案》。该议案尚需提交公司股东大会审 议。 二、变更公司注册地址的相关情况 因青岛英派斯体育产业园建成投产，公司产区整体搬迁至前述产业园所在地 址，公司拟将注册地址由"山东省青岛市即墨市华山二路 369 号"变更为"山东 省青岛市即墨区马山路 ...

青岛英派斯健康科技股份有限公司 | | 青岛英派 斯健康发 | 全资子 | 其他应 | 6,991.53 | 831.83 | | 150.57 | 7,672.79 | 往来 | 非经营性往 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | 展有限公 | 公司 | 收款 | | | | | | 款 | 来 | | 上市公司的子公司 及其附属企业 | 司 青岛英派 斯商贸有 限公司 | 全资子 公司 | 其他应 收款 | 45.11 | 0.12 | | | 45.23 | 往来 款 | 非经营性往 来 | | | 深圳英派 斯体育科 | 全资子 | 其他应 | | | | | | 往来 | 非经营性往 | | | 技有限公 | 公司 | 收款 | 0.04 | 0.73 | | | 0.77 | 款 | 来 | | | 司 | | | | | | | | | | | 其他关联方及其附 | - | - | - | | | - | | | - | - | | 属企业 | | | | | | | | | | | | ...

证券代码：002899 证券简称：英派斯 公告编号：2025-030 青岛英派斯健康科技股份有限公司 2025 年半年度募集资金存放、管理与使用情况的专项报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 一、募集资金基本情况 （一）实际募集资金金额、资金到账时间 1、首次公开发行股票 经中国证券监督管理委员会《关于核准青岛英派斯健康科技股份有限公司首 次公开发行股票的批复》（证监许可[2017]1539 号）核准，青岛英派斯健康科技 股份有限公司（以下简称"公司"）向社会公开发行人民币普通股（A 股）30,000,000 股，每股面值 1 元，每股发行价格 16.05 元，募集资金总额人民币 481,500,000.00 元，扣除各项发行费用合计人民币 48,294,558.28 元，实际募集资金净额为 433,205,441.72 元。截止 2017 年 9 月 11 日，实际募集资金净额 433,205,441.72 元已全部到位，上述募集资金到位情况已经山东和信会计师事务所（特殊普通合 伙）（现更名为和信会计师事务所（特殊普通合伙））出具和信验字（2 ...

青岛英派斯健康科技股份有限公司 2025 年半年度财务报告 （未经审计） 2025 年 8 月 合并资产负债表 编制单位：青岛英派斯健康科技股份有限公司 单位：元 币种：人民币 法定代表人： 主管会计工作负责人： 会计机构负责人： 1 项目 附注 2025年6月30日 2024年12月31日 流动资产： 货币资金 五、1 360,981,235.18 476,862,517.58 交易性金融资产 五、2 295,249,231.64 326,200,117.70 衍生金融资产 - - 应收票据 五、3 602,054.90 3,417,150.00 应收账款 五、4 213,140,423.80 190,773,912.23 应收款项融资 - - 预付款项 五、5 16,312,954.27 15,846,203.98 其他应收款 五、6 10,980,040.61 19,572,190.08 其中：应收利息 - - 应收股利 - - 存货 五、7 184,904,503.31 237,540,274.94 其中：数据资源 合同资产 五、8 34,598,193.39 39,613,183.76 持有待售资产 ...

证券代码：002899 证券简称：英派斯 公告编号：2025-034 青岛英派斯健康科技股份有限公司 关于召开 2025 年第一次临时股东大会的通知 （1）现场会议时间：2025 年 9 月 16 日（周二）下午 14:50 （2）网络投票时间：2025 年 9 月 16 日（周二） 其中，通过深圳证券交易所交易系统进行网络投票的具体时间为：2025 年 9 月 16 日上午 9:15—9:25，9:30—11:30 和 13:00—15:00；通过深圳证券交易所互 联网投票系统投票的具体时间为：2025 年 9 月 16 日上午 9:15 至下午 15:00 期间 的任意时间。 5．会议的召开方式： 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 青岛英派斯健康科技股份有限公司（以下简称"公司"或"本公司"）第四 届董事会 2025 年第四次会议于 2025 年 8 月 29 日审议通过了《关于提请召开 2025 年第一次临时股东大会的议案》，公司 2025 年第一次临时股东大会定于 2025 年 9 月 16 日召开。现将会议召开有关事项通知如下： 一、召 ...